G43
Conditions
Interventions
Group 1: Intervention group (usual care + physiotherapy): Usual care means that the participants continue their usual migraine therapy (medication, medical, therapeutic). The participants in this grou
a record is kept of whether and in what form therapy has been provided. Following this period, after the follow-up examination, the control group will also receive physiotherapy = delayed treatment, a
Sponsors
Universität zu Lübeck
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: The participant has been diagnosed with migraine with or without aura by a specialist in neurology or general medicine. This will be confirmed by the participant in a separate question during the collection of the outcome parameters. The participant has been documenting their own headache parameters in the form of a headache calendar/diary for at least three months. The participant uses the Migraine App of the Schmerzklinik Kiel to document their headache parameters for the duration of their participation in the study. The participant has given their consent to participate in the study.
Exclusion criteria
Exclusion criteria: The participant has had physiotherapy in the past 3 months for treatment of upper body complaints, specifically the shoulder-neck region and the jaw. The participant is pregnant. The participant has insufficient language skills to answer the questionnaires provided. The participant has insufficient cognitive abilities, e.g. due to dementia or mental disabilities. The headache persists due to a pathology or injury of the cervical spine. The headache to be evaluated does not meet the criteria for migraine (according to the international classification of headache disorders ICHD-3).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Headache days (migraine) per month, these are recorded using a headache calendar/diary kept by participating migraine patients. The measurement times for both study arms are: baseline measurement (T1), effect measurement after 3 months (T2) and follow-up survey 6 months after the initial examination (T3). For study arm 2 (usual care + delayed treatment), a further, final measurement/effect measurement is carried out 3 months after the start of physiotherapy (T4) = approx. 9 months after the initial examination. | — |
Secondary
| Measure | Time frame |
|---|---|
| Migraine Disability Assessment (Headache Impact Test - HIT-6); Disability due to neck pain (Neck Disability Index - NDI); Onset of neck pain (three-part selection query: a) only in connection with migraine attacks (before, during or after the headache), b) only between migraine attacks, c) both during and between attacks); Headache Screening Questionnaire (HSQ-DE); Questionnaire on headache management and self-efficacy (HMSE-G / FKMS); Fear of Attacks in Migraine (FAMI); Increased Sensitivity (Allodynia Symptom Checklist - ASC-12); Depression Anxiety Stress Scales (DASS) The measurement times for both study arms are: baseline measurement (T1), effect measurement after 3 months (T2) and follow-up survey 6 months after the initial examination (T3). For study arm 2 (usual care + delayed treatment), a further, final measurement/effect measurement is carried out 3 months after the start of physiotherapy (T4) = approx. 9 months after the initial examination. | — |
Countries
Germany
Contacts
Public ContactKerstin Lüdtke
Universität zu Lübeck
Outcome results
None listed